Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Injection Influenza Vaccine market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Injection Influenza Vaccine Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Injection Influenza Vaccine Market by Type [Analysis by Value from 2020 to 2031]:
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
Injection Influenza Vaccine Market by Application [Analysis by Value from 2020 to 2031]:
- 6 Months to 3 Years
- > 3 Years
Key Players in the Injection Influenza Vaccine Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- Jiangsu GDK
- KM Biologics
Injection Influenza Vaccine Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Injection Influenza Vaccine Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Injection Influenza Vaccine Market Size & Demand Forecast (2031)
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Injection Influenza Vaccine Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Injection Influenza Vaccine Segmentation & Growth Forecasts
The study systematically breaks down the Global Injection Influenza Vaccine Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Injection Influenza Vaccine Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Injection Influenza Vaccine market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Injection Influenza Vaccine Definition
1.2 Global Injection Influenza Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Injection Influenza Vaccine Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Injection Influenza Vaccine Market Size, 2020-2031
1.2.3 Global Injection Influenza Vaccine Average Selling Price (ASP), 2020-2031
1.3 China Injection Influenza Vaccine Market Size and Forecast
1.3.1 By Consumption Value, China Injection Influenza Vaccine Market Size, 2020-2031
1.3.2 By Sales Quantity, China Injection Influenza Vaccine Market Size, 2020-2031
1.3.3 China Injection Influenza Vaccine Average Selling Price (ASP), 2020-2031
1.4 Share of China Injection Influenza Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Injection Influenza Vaccine Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Injection Influenza Vaccine Market Share in Global, 2020-2031
1.4.3 Injection Influenza Vaccine Market Size: China VS Global, 2020-2031
1.5 Injection Influenza Vaccine Market Dynamics
1.5.1 Injection Influenza Vaccine Market Drivers
1.5.2 Injection Influenza Vaccine Market Restraints
1.5.3 Injection Influenza Vaccine Industry Trends
1.5.4 Injection Influenza Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Injection Influenza Vaccine, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Injection Influenza Vaccine, Global Market Share by Company, 2020-2025
2.3 Injection Influenza Vaccine Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Injection Influenza Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Injection Influenza Vaccine Concentration Ratio
2.6 Global Injection Influenza Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Injection Influenza Vaccine Manufacturers Product Type
2.8 Head Office and Injection Influenza Vaccine Production Site of Key Manufacturer
2.9 Injection Influenza Vaccine Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Injection Influenza Vaccine, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Injection Influenza Vaccine, China Market Share by Company, 2020-2025
3.3 China Injection Influenza Vaccine Injection Influenza Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Injection Influenza Vaccine Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Injection Influenza Vaccine Capacity by Region
4.3 Global Injection Influenza Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Injection Influenza Vaccine Production by Region, 2020-2031
4.5 Global Injection Influenza Vaccine Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
5.1 Injection Influenza Vaccine Industry Chain
5.2 Injection Influenza Vaccine Upstream Analysis
5.2.1 Injection Influenza Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Injection Influenza Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Injection Influenza Vaccine Production Mode
5.6 Injection Influenza Vaccine Procurement Model
5.7 Injection Influenza Vaccine Industry Sales Model and Sales Channels
5.7.1 Injection Influenza Vaccine Sales Model
5.7.2 Injection Influenza Vaccine Typical Distributors
6 Sights by Product Type
6.1 Injection Influenza Vaccine Classification
6.1.1 Trivalent Influenza Vaccine
6.1.2 Quadrivalent Influenza Vaccine
6.2 by Type, Global Injection Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Injection Influenza Vaccine Consumption Value, 2020-2031
6.4 by Type, Global Injection Influenza Vaccine Sales Quantity, 2020-2031
6.5 by Type, Global Injection Influenza Vaccine Average Selling Price (ASP), 2020-2031
7 Sights by Application
7.1 Injection Influenza Vaccine Segment by Application
7.1.1 6 Months to 3 Years
7.1.2 > 3 Years
7.2 by Application, Global Injection Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Injection Influenza Vaccine Consumption Value, 2020-2031
7.4 by Application, Global Injection Influenza Vaccine Sales Quantity, 2020-2031
7.5 by Application, Global Injection Influenza Vaccine Price, 2020-2031
8 Sales Sights by Region
8.1 By Region, Global Injection Influenza Vaccine Consumption Value, 2020 VS 2024 VS 2031
8.2 By Region, Global Injection Influenza Vaccine Consumption Value, 2020-2031
8.3 By Region, Global Injection Influenza Vaccine Sales Quantity, 2020-2031
8.4 North America
8.4.1 North America Injection Influenza Vaccine Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Injection Influenza Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Injection Influenza Vaccine Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Injection Influenza Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Injection Influenza Vaccine Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Injection Influenza Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Injection Influenza Vaccine Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Injection Influenza Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Injection Influenza Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
9.2 By Country, Global Injection Influenza Vaccine Consumption Value, 2020-2031
9.3 By Country, Global Injection Influenza Vaccine Sales Quantity, 2020-2031
9.4 United States
9.4.1 United States Injection Influenza Vaccine Market Size, 2020-2031
9.4.2 by Type, United States Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.4.3 by Application, United States Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Injection Influenza Vaccine Market Size, 2020-2031
9.5.2 by Type, Europe Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.5.3 by Application, Europe Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.6 China
9.6.1 China Injection Influenza Vaccine Market Size, 2020-2031
9.6.2 by Type, China Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.6.3 by Application, China Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Injection Influenza Vaccine Market Size, 2020-2031
9.7.2 by Type, Japan Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.7.3 by Application, Japan Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Injection Influenza Vaccine Market Size, 2020-2031
9.8.2 by Type, South Korea Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.8.3 by Application, South Korea Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Injection Influenza Vaccine Market Size, 2020-2031
9.9.2 by Type, Southeast Asia Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.9.3 by Application, Southeast Asia Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.10 India
9.10.1 India Injection Influenza Vaccine Market Size, 2020-2031
9.10.2 by Type, India Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.10.3 by Application, India Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Injection Influenza Vaccine Market Size, 2020-2031
9.11.2 by Type, Middle East & Africa Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
9.11.3 by Application, Middle East & Africa Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
10.1 Sanofi
10.1.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.1.2 Sanofi Injection Influenza Vaccine Models, Specifications, and Application
10.1.3 Sanofi Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Sanofi Company Profile and Main Business
10.1.5 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Company Information, Head Office, Market Area, and Industry Position
10.2.2 CSL Injection Influenza Vaccine Models, Specifications, and Application
10.2.3 CSL Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.2.4 CSL Company Profile and Main Business
10.2.5 CSL Recent Developments
10.3 GSK
10.3.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.3.2 GSK Injection Influenza Vaccine Models, Specifications, and Application
10.3.3 GSK Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.3.4 GSK Company Profile and Main Business
10.3.5 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Company Information, Head Office, Market Area, and Industry Position
10.4.2 Viatris Injection Influenza Vaccine Models, Specifications, and Application
10.4.3 Viatris Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Viatris Company Profile and Main Business
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.5.2 AstraZeneca Injection Influenza Vaccine Models, Specifications, and Application
10.5.3 AstraZeneca Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.5.4 AstraZeneca Company Profile and Main Business
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
10.6.2 Hualan Bio Injection Influenza Vaccine Models, Specifications, and Application
10.6.3 Hualan Bio Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Hualan Bio Company Profile and Main Business
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Company Information, Head Office, Market Area, and Industry Position
10.7.2 Changchun Institute of Biological Injection Influenza Vaccine Models, Specifications, and Application
10.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Changchun Institute of Biological Company Profile and Main Business
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Company Information, Head Office, Market Area, and Industry Position
10.8.2 Sinovac Injection Influenza Vaccine Models, Specifications, and Application
10.8.3 Sinovac Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Sinovac Company Profile and Main Business
10.8.5 Sinovac Recent Developments
10.9 Jiangsu GDK
10.9.1 Jiangsu GDK Company Information, Head Office, Market Area, and Industry Position
10.9.2 Jiangsu GDK Injection Influenza Vaccine Models, Specifications, and Application
10.9.3 Jiangsu GDK Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Jiangsu GDK Company Profile and Main Business
10.9.5 Jiangsu GDK Recent Developments
10.10 KM Biologics
10.10.1 KM Biologics Company Information, Head Office, Market Area, and Industry Position
10.10.2 KM Biologics Injection Influenza Vaccine Models, Specifications, and Application
10.10.3 KM Biologics Injection Influenza Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
10.10.4 KM Biologics Company Profile and Main Business
10.10.5 KM Biologics Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Injection Influenza Vaccine Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Injection Influenza Vaccine Market Restraints
Table 3. Injection Influenza Vaccine Market Trends
Table 4. Injection Influenza Vaccine Industry Policy
Table 5. Global Injection Influenza Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Injection Influenza Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Injection Influenza Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
Table 8. Global Injection Influenza Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 9. Global Injection Influenza Vaccine Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)
Table 10. Global Injection Influenza Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Injection Influenza Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Injection Influenza Vaccine Manufacturers Product Type
Table 13. Head Office and Injection Influenza Vaccine Production Site of Key Manufacturer
Table 14. Injection Influenza Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Injection Influenza Vaccine Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 16. China Injection Influenza Vaccine Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 17. China Injection Influenza Vaccine Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024
Table 18. China Injection Influenza Vaccine Sales Quantity by Company, 2020-2025, Ranked by Data of 2024
Table 19. Global Injection Influenza Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)
Table 20. Global Injection Influenza Vaccine Production by Region, 2020-2025, (K Units)
Table 21. Global Injection Influenza Vaccine Production Forecast by Region, 2026-2031, (K Units)
Table 22. Global Key Players of Injection Influenza Vaccine Upstream (Raw Materials)
Table 23. Global Injection Influenza Vaccine Typical Customers
Table 24. Injection Influenza Vaccine Typical Distributors
Table 25. by Type, Global Injection Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 26. by Application, Global Injection Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 27. By Region, Global Injection Influenza Vaccine Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 28. By Region, Global Injection Influenza Vaccine Consumption Value, 2020-2031, US$ Million
Table 29. By Region, Global Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Table 30. By Country, Global Injection Influenza Vaccine Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 31. By Country, Global Injection Influenza Vaccine Consumption Value, 2020-2031, US$ Million
Table 32. By Country, Global Injection Influenza Vaccine Consumption Value Market Share, 2020-2031
Table 33. By Country, Global Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Table 34. By Country, Global Injection Influenza Vaccine Sales Quantity Market Share, 2020-2031
Table 35. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 36. Sanofi Injection Influenza Vaccine Models, Specifications, and Application
Table 37. Sanofi Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 38. Sanofi Company Profile and Main Business
Table 39. Sanofi Recent Developments
Table 40. CSL Company Information, Head Office, Market Area, and Industry Position
Table 41. CSL Injection Influenza Vaccine Models, Specifications, and Application
Table 42. CSL Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 43. CSL Company Profile and Main Business
Table 44. CSL Recent Developments
Table 45. GSK Company Information, Head Office, Market Area, and Industry Position
Table 46. GSK Injection Influenza Vaccine Models, Specifications, and Application
Table 47. GSK Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 48. GSK Company Profile and Main Business
Table 49. GSK Recent Developments
Table 50. Viatris Company Information, Head Office, Market Area, and Industry Position
Table 51. Viatris Injection Influenza Vaccine Models, Specifications, and Application
Table 52. Viatris Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 53. Viatris Company Profile and Main Business
Table 54. Viatris Recent Developments
Table 55. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 56. AstraZeneca Injection Influenza Vaccine Models, Specifications, and Application
Table 57. AstraZeneca Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 58. AstraZeneca Company Profile and Main Business
Table 59. AstraZeneca Recent Developments
Table 60. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
Table 61. Hualan Bio Injection Influenza Vaccine Models, Specifications, and Application
Table 62. Hualan Bio Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 63. Hualan Bio Company Profile and Main Business
Table 64. Hualan Bio Recent Developments
Table 65. Changchun Institute of Biological Company Information, Head Office, Market Area, and Industry Position
Table 66. Changchun Institute of Biological Injection Influenza Vaccine Models, Specifications, and Application
Table 67. Changchun Institute of Biological Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 68. Changchun Institute of Biological Company Profile and Main Business
Table 69. Changchun Institute of Biological Recent Developments
Table 70. Sinovac Company Information, Head Office, Market Area, and Industry Position
Table 71. Sinovac Injection Influenza Vaccine Models, Specifications, and Application
Table 72. Sinovac Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 73. Sinovac Company Profile and Main Business
Table 74. Sinovac Recent Developments
Table 75. Jiangsu GDK Company Information, Head Office, Market Area, and Industry Position
Table 76. Jiangsu GDK Injection Influenza Vaccine Models, Specifications, and Application
Table 77. Jiangsu GDK Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 78. Jiangsu GDK Company Profile and Main Business
Table 79. Jiangsu GDK Recent Developments
Table 80. KM Biologics Company Information, Head Office, Market Area, and Industry Position
Table 81. KM Biologics Injection Influenza Vaccine Models, Specifications, and Application
Table 82. KM Biologics Injection Influenza Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025
Table 83. KM Biologics Company Profile and Main Business
Table 84. KM Biologics Recent Developments
List of Figures
Figure 1. Injection Influenza Vaccine Picture
Figure 2. Global Injection Influenza Vaccine Consumption Value, (US$ million) & (2020-2031)
Figure 3. Global Injection Influenza Vaccine Sales Quantity, (K Units) & (2020-2031)
Figure 4. Global Injection Influenza Vaccine Average Selling Price (ASP), (2020-2031) & (US$/Unit)
Figure 5. China Injection Influenza Vaccine Consumption Value, (US$ million) & (2020-2031)
Figure 6. China Injection Influenza Vaccine Sales Quantity (K Units) & (2020-2031)
Figure 7. China Injection Influenza Vaccine Average Selling Price (ASP), (US$/Unit) & (2020-2031)
Figure 8. By Consumption Value, China Injection Influenza Vaccine Market Share of Global, 2020-2031
Figure 9. By Sales Quantity, China Injection Influenza Vaccine Market Share of Global, 2020-2031
Figure 10. Global Injection Influenza Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 11. China Injection Influenza Vaccine Key Participants, Market Share, 2024
Figure 12. Global Injection Influenza Vaccine Capacity, Production and Capacity Utilization, 2020-2031
Figure 13. Global Injection Influenza Vaccine Capacity Market Share by Region, 2024 VS 2031
Figure 14. Global Injection Influenza Vaccine Production Market Share & Forecast by Region, 2020-2031
Figure 15. Injection Influenza Vaccine Industry Chain
Figure 16. Injection Influenza Vaccine Procurement Model
Figure 17. Injection Influenza Vaccine Sales Model
Figure 18. Injection Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Trivalent Influenza Vaccine
Figure 20. Quadrivalent Influenza Vaccine
Figure 21. by Type, Global Injection Influenza Vaccine Consumption Value, 2020-2031, US$ Million
Figure 22. by Type, Global Injection Influenza Vaccine Consumption Value Market Share, 2020-2031
Figure 23. by Type, Global Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 24. by Type, Global Injection Influenza Vaccine Sales Quantity Market Share, 2020-2031
Figure 25. by Type, Global Injection Influenza Vaccine Average Selling Price (ASP), 2020-2031, (US$/Unit)
Figure 26. 6 Months to 3 Years
Figure 27. > 3 Years
Figure 28. by Application, Global Injection Influenza Vaccine Consumption Value, 2020-2031, US$ Million
Figure 29. by Application, Global Injection Influenza Vaccine Revenue Market Share, 2020-2031
Figure 30. by Application, Global Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 31. by Application, Global Injection Influenza Vaccine Sales Quantity Market Share, 2020-2031
Figure 32. by Application, Global Injection Influenza Vaccine Price, 2020-2031, (US$/Unit)
Figure 33. By Region, Global Injection Influenza Vaccine Consumption Value Market Share, 2020-2031
Figure 34. By Region, Global Injection Influenza Vaccine Sales Quantity Market Share, 2020-2031
Figure 35. North America Injection Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 36. By Country, North America Injection Influenza Vaccine Consumption Value Market Share, 2024
Figure 37. Europe Injection Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 38. By Country, Europe Injection Influenza Vaccine Consumption Value Market Share, 2024
Figure 39. Asia Pacific Injection Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 40. By Country/Region, Asia Pacific Injection Influenza Vaccine Consumption Value Market Share, 2024
Figure 41. South America Injection Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 42. By Country, South America Injection Influenza Vaccine Consumption Value Market Share, 2024
Figure 43. Middle East & Africa Injection Influenza Vaccine Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 44. United States Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 45. by Type, United States Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 46. by Application, United States Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 47. Europe Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 48. by Type, Europe Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 49. by Application, Europe Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 50. China Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 51. by Type, China Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 52. by Application, China Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 53. Japan Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 54. by Type, Japan Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 55. by Application, Japan Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 56. South Korea Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 57. by Type, South Korea Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 58. by Application, South Korea Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 59. Southeast Asia Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 60. by Type, Southeast Asia Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 61. by Application, Southeast Asia Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 62. India Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 63. by Type, India Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 64. by Application, India Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 65. Middle East & Africa Injection Influenza Vaccine Sales Quantity, 2020-2031, (K Units)
Figure 66. by Type, Middle East & Africa Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 67. by Application, Middle East & Africa Injection Influenza Vaccine Sales Quantity Market Share, 2024 VS 2031
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up Approaches
Figure 71. Top-down Approaches
Research Methodology:
Injection Influenza Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|